Bicon Pharmaceutical
Bicon Pharmaceutical manufactures and distributes pharmaceutical raw materials, patent medicines, chemicals, vaccines, and more.
Business Model: B2B
Revenue: $0
Employees: 1,001-5,000
Rankings
Industries / Tags:
Detailed Bicon Pharmaceutical Information
Geographic Data
Address:
City: Xian
State: Hunan
Zip:
Country: China
Financial Info
Stage:
post ipo equity
Raised Last:
$250M
Raised Total:$250M
Social
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Bicon Pharmaceutical is a large-scale pharmaceutical enterprise group with integrated businesses covering pharmaceutical raw materials, Chinese patent medicines, chemicals, biological agents, vaccine R&a;D, production and marketing. The production base of Bicon Pharmaceutical covers an area of 7.33 hectares and has the largest monomer workshop in Asia that meets the good manufacturing practice (GMP) standard. It has a sterilization space of 32,500 square meters and 15 production lines of tablets, capsules, soft capsules, granules, ointment, oral solution, syrup, large-volume injections, small-volume injections, and other products. The annual production capacity of the base is more than RMB 6 billion. The company also operates a herbal medicine extraction workshop of 5,000 square meters with an annual extraction capacity of 8,000 tons. Bicon Pharmaceutical was founded in 1997 and became a foreign-owned enterprise owned by Hong Kong Bicon International with a registered capital of RMB 937 million.
Contact Phone:
Contact Email:
Bicon Pharmaceutical went public on 5/25/2010 on the SZSE
Listed Exchange:
SZSE
IPO Date:
5/25/2010
Ticker Symbol:
002411
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 11/2009 | Series A | 2 | - |
Sequoia Capital SIG China (SIG Asia Investments) Sequoia Capital SIG China (SIG Asia Investments) |
3/2012 | Post-IPO Equity | 1 | $250M |
PAG PAG |
11/2009 | Series A | 2 | - |
Sequoia Capital SIG China (SIG Asia Investments) Sequoia Capital SIG China (SIG Asia Investments) |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
